Richter plans no acquisitions, looks to Russia for growth

Pharma

Pharmaceuticals company Richter Gedeon Rt is planning no acquisitions, rather it aims to grow organically relying on its markets in CIS countries while concentrating on generics and high-margin gynecological products as well as original patents, CEO Erik Bogsch said in an interview with internet business portal portfolio.hu published on Tuesday.

Richter's growth will be ensured by the stability of Russia's economy and politics, Bogsch said. Richter has started production at a local unit of a wide range of products at the right time, as many of Richter's drugs have been included on a special list of state-subsidized medicines, and Russians are now able to afford pricier drugs. Bogsch noted that local production was a condition for inclusion of Richter's drugs on the state-subsidized medicines list.
Richter's unconsolidated revenue from exports to CIS countries rose 40.1% to $215.9 million in 2005 and accounted for nearly half of total export revenue. Revenue from sales of drugs on Russia's state-subsidized medicines list came to $30 million.

Alteo Shareholders Approve HUF 400/Share Dividend Green Energy

Alteo Shareholders Approve HUF 400/Share Dividend

Bulgaria's Household Income, Spending Rise 20% in 2023 World

Bulgaria's Household Income, Spending Rise 20% in 2023

1/3 of White-collar Employees Work From Home 1-2 Days/Week HR

1/3 of White-collar Employees Work From Home 1-2 Days/Week

Gastrotourism Alive and Well in Hungary Tourism

Gastrotourism Alive and Well in Hungary

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.